Published in Ann Nucl Med on July 01, 2005
Molecular optical imaging with radioactive probes. PLoS One (2010) 2.36
scFv antibody: principles and clinical application. Clin Dev Immunol (2012) 1.64
Development of radioimmunotherapeutic and diagnostic antibodies: an inside-out view. Nucl Med Biol (2007) 1.44
Variations of chromosomes 2 and 3 gene expression profiles among pulmonary telocytes, pneumocytes, airway cells, mesenchymal stem cells and lymphocytes. J Cell Mol Med (2014) 1.01
Comparative biodistributions of pretargeted radioimmunoconjugates targeting CD20, CD22, and DR molecules on human B-cell lymphomas. Blood (2007) 0.96
68Ga-labelled recombinant antibody variants for immuno-PET imaging of solid tumours. Eur J Nucl Med Mol Imaging (2010) 0.89
Genes associated with prognosis after surgery for malignant pleural mesothelioma promote tumor cell survival in vitro. BMC Cancer (2011) 0.85
Zebularine significantly sensitises MEC1 cells to external irradiation and radiopharmaceutical therapy when administered sequentially in vitro. Cell Biol Int (2013) 0.77
Evaluation of two (125)I-radiolabeled acridine derivatives for Auger-electron radionuclide therapy of melanoma. Invest New Drugs (2014) 0.75
Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med (2004) 2.55
Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer. World J Surg (2004) 1.87
The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma. Cancer (2005) 1.64
MR imaging in the evaluation of chronic or recurrent headache. Radiology (2005) 1.64
Esophageal anthracosis: lesion mimicking malignant melanoma. Pathol Int (2002) 1.46
FK506 controls CD40L-induced systemic autoimmunity in mice. J Invest Dermatol (2006) 1.42
Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients. Chest (2007) 1.41
Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma. Cancer (2002) 1.28
Biologic correlation of 2-[18F]-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors. J Clin Oncol (2010) 1.27
Quantitative perfusion map of malignant liver tumors, created from dynamic computed tomography data. Acad Radiol (2004) 1.25
Usefulness of FDG-PET for early prediction of the response to gefitinib in non-small cell lung cancer. Lung Cancer (2007) 1.23
Active MAC-1 (CD11b/CD18) on DCs inhibits full T-cell activation. Blood (2006) 1.23
18F-fluorodeoxyglucose positron emission tomography: useful technique for predicting malignant potential of gastrointestinal stromal tumors. World J Surg (2005) 1.22
Development of a 111In-labeled peptide derivative targeting a chemokine receptor, CXCR4, for imaging tumors. Nucl Med Biol (2006) 1.22
Evaluation of hemangioma by positron emission tomography: role in a multimodality approach. J Comput Assist Tomogr (2003) 1.21
Effect of contrast-enhanced computed tomography on diagnosis and management of acute abdomen in adults. Clin Radiol (2002) 1.18
Temporal change in human nicotinic acetylcholine receptor after smoking cessation: 5IA SPECT study. J Nucl Med (2007) 1.17
Jejunogastric intussusception: life-threatening complication occuring 55 years after gastrojejunostomy. Intern Med (2009) 1.17
PET and PET/CT using 18F-FDG in the diagnosis and management of cancer patients. Int J Clin Oncol (2006) 1.16
Analysis models to assess cost effectiveness of the four strategies for the work-up of solitary pulmonary nodules. Med Sci Monit (2004) 1.14
Pulmonary artery intimal sarcoma: the role of ¹⁸F-fluorodeoxyglucose positron emission tomography in monitoring response to treatment. Jpn J Radiol (2011) 1.11
Body diffusion-weighted MR imaging using high b-value for malignant tumor screening: usefulness and necessity of referring to T2-weighted images and creating fusion images. Acad Radiol (2007) 1.10
HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions. Psychiatry Res (2007) 1.09
Fluorine-18-alpha-methyltyrosine positron emission tomography for diagnosis and staging of lung cancer: a clinicopathologic study. Clin Cancer Res (2007) 1.07
The clinical application of (18)F-fluorodeoxyglucose positron emission tomography to predict survival in patients with operable esophageal cancer. Cancer (2009) 1.07
Comparison between whole-body positron emission tomography and bone scintigraphy in evaluating bony metastases of esophageal carcinomas. Anticancer Res (2005) 1.06
Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors. Eur J Nucl Med Mol Imaging (2004) 1.05
FDG-PET for evaluating musculoskeletal tumors: a review. J Orthop Sci (2003) 1.04
Magnetic resonance (MR) differential diagnosis of breast tumors using apparent diffusion coefficient (ADC) on 1.5-T. J Magn Reson Imaging (2009) 1.04
Evaluation of hepatic lesions and hepatic parenchyma using diffusion-weighted reordered turboFLASH magnetic resonance images. J Magn Reson Imaging (2002) 1.04
Phosphorescent light-emitting iridium complexes serve as a hypoxia-sensing probe for tumor imaging in living animals. Cancer Res (2010) 1.03
Expression of Glut-1 and Glut-3 in untreated oral squamous cell carcinoma compared with FDG accumulation in a PET study. Eur J Nucl Med Mol Imaging (2003) 1.03
Positron emission tomography imaging and biodistribution of vascular endothelial growth factor with 64Cu-labeled bevacizumab in colorectal cancer xenografts. Cancer Sci (2010) 1.02
The combination of multi-voxel MR spectroscopy with MR imaging improve the diagnostic accuracy for localization of prostate cancer. Anticancer Res (2003) 1.02
Transport of 3-fluoro-L-α-methyl-tyrosine by tumor-upregulated L-type amino acid transporter 1: a cause of the tumor uptake in PET. J Nucl Med (2012) 1.02
Brain microhemorrhages detected on T2*-weighted gradient-echo MR images. AJNR Am J Neuroradiol (2003) 1.02
PET evaluation of fatty tumors in the extremity: possibility of using the standardized uptake value (SUV) to differentiate benign tumors from liposarcoma. Ann Nucl Med (2005) 1.01
Successful interventional management for subclavian artery injury secondary to internal jugular catheterization: a report of two cases. Cardiovasc Intervent Radiol (2009) 0.99
¹⁸F-FAMT uptake correlates with tumor proliferative activity in oral squamous cell carcinoma: comparative study with ¹⁸F-FDG PET and immunohistochemistry. Ann Nucl Med (2010) 0.99
Radiation exposure from CT examinations in Japan. BMC Med Imaging (2010) 0.99
MR signal of the solid portion of pilocytic astrocytoma on T2-weighted images: is it useful for differentiation from medulloblastoma? Neuroradiology (2006) 0.98
Expression of glucose transporters and hexokinase II in cholangiocellular carcinoma compared using [18F]-2-fluro-2-deoxy-D-glucose positron emission tomography. Cancer Sci (2008) 0.98
Correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in non-small cell lung cancer. Cancer Sci (2009) 0.98
Present role and future prospects of positron emission tomography in clinical oncology. Cancer Sci (2006) 0.97
Inverse correlation between tumor perfusion and glucose uptake in human head and neck tumors. Acad Radiol (2007) 0.96
Prevalence of abnormal findings on brain magnetic resonance (MR) examinations in adult participants of brain docking. BMC Neurol (2005) 0.96
Development of injectable O-15 oxygen and estimation of rat OEF. J Cereb Blood Flow Metab (2003) 0.96
Clinical and imaging characteristics of localized megalencephaly: a retrospective comparison of diffuse hemimegalencephaly and multilobar cortical dysplasia. Neuroradiology (2009) 0.95
Sentinel lymph nodes with technetium-99m colloidal rhenium sulfide in patients with esophageal carcinoma. Cancer (2003) 0.95
Peroxisome proliferator-activated receptor-γ in capillary endothelia promotes fatty acid uptake by heart during long-term fasting. J Am Heart Assoc (2013) 0.95
Capillary endothelial fatty acid binding proteins 4 and 5 play a critical role in fatty acid uptake in heart and skeletal muscle. Arterioscler Thromb Vasc Biol (2013) 0.95
Reliable measurement procedure of virtual touch tissue quantification with acoustic radiation force impulse imaging. J Ultrasound Med (2011) 0.94
Magnetic resonance imaging findings of extrapelvic endometriosis of the round ligament. Jpn J Radiol (2009) 0.94
Development of a rhenium-186-labeled MAG3-conjugated bisphosphonate for the palliation of metastatic bone pain based on the concept of bifunctional radiopharmaceuticals. Bioconjug Chem (2005) 0.94
Augmented antibody response with premature germinal center regression in CD40L transgenic mice. J Immunol (2010) 0.94
Effectiveness of FDG-PET in screening of synchronous cancer of other organs in patients with esophageal cancer. Anticancer Res (2014) 0.93
Quantification of human nicotinic acetylcholine receptors with 123I-5IA SPECT. J Nucl Med (2004) 0.93
Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma. Anticancer Res (2003) 0.92
Clinical implication of glucose transport and metabolism evaluated by 18F-FDG PET in hepatocellular carcinoma. Int J Oncol (2008) 0.91
Ectopic CD40 ligand expression on B cells triggers intestinal inflammation. J Immunol (2004) 0.91
A phase I radioimmunolocalization trial of humanized monoclonal antibody huA33 in patients with gastric carcinoma. Cancer Sci (2006) 0.91
Protective effect of zinc against ischemic neuronal injury in a middle cerebral artery occlusion model. J Pharmacol Sci (2006) 0.90
Usefulness of positron emission tomography for assessing the response of neoadjuvant chemoradiotherapy in patients with esophageal cancer. Am J Surg (2002) 0.90
Prediction of response to definitive chemoradiotherapy in esophageal cancer using positron emission tomography. Anticancer Res (2007) 0.90
Variability of lesion detectability and standardized uptake value according to the acquisition procedure and reconstruction among five PET scanners. Ann Nucl Med (2008) 0.90
Air embolism detected during computed tomography fluoroscopically guided transthoracic needle biopsy. Cardiovasc Intervent Radiol (2008) 0.90
Image Fusion System Using PACS for MRI, CT, and PET Images. Clin Positron Imaging (1999) 0.89
Imaging and biodistribution of Her2/neu expression in non-small cell lung cancer xenografts with Cu-labeled trastuzumab PET. Cancer Sci (2009) 0.88
Radioimmunotherapy of human synovial sarcoma using a monoclonal antibody against FZD10. Cancer Sci (2008) 0.88
Japanese phase II study of 90Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma. Cancer Sci (2008) 0.88
Relationship between 18F-FDG uptake on positron emission tomography and molecular biology in malignant pleural mesothelioma. Eur J Cancer (2012) 0.87
Normal cranial nerves in the cavernous sinuses: contrast-enhanced three-dimensional constructive interference in the steady state MR imaging. AJNR Am J Neuroradiol (2005) 0.87
Dual functional molecular imaging probe targeting CD20 with PET and optical imaging. Oncol Rep (2009) 0.87
Role of F-18 FDG PET/CT in assessing IgG4-related disease with inflammation of head and neck glands. Ann Nucl Med (2015) 0.87
An important role of CD80/CD86-CTLA-4 signaling during photocarcinogenesis in mice. J Immunol (2005) 0.87
Lack of evidence for apoptosis as a cause of delayed onset paraplegia after spinal cord ischemia in rabbits. Anesth Analg (2003) 0.87
Detection of metastatic lesions from malignant pheochromocytoma and paraganglioma with diffusion-weighted magnetic resonance imaging: comparison with 18F-FDG positron emission tomography and 123I-MIBG scintigraphy. Ann Nucl Med (2008) 0.86
High [18F] 2-fluoro-2-deoxy-D-glucose (FDG) uptake of adrenocortical adenoma showing subclinical Cushing's syndrome. Ann Nucl Med (2003) 0.86
Predicting cetuximab accumulation in KRAS wild-type and KRAS mutant colorectal cancer using 64Cu-labeled cetuximab positron emission tomography. Cancer Sci (2011) 0.86